Bayer Launches New Healthy-Aging Ecosystem for Consumers

BayerCombining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging space by offering consumers new tools to help them support their healthy-aging journey with its new Age Factor™ ecosystem.

The ecosystem approach is designed to go "beyond the pill" by addressing key consumer needs at multiple steps in their health journey from awareness, education, and engagement to assessment and action. Powered by digital tools, the goal is to help consumers make smarter, more informed decisions about their own health.

"Precision health is making self-care even more consumer-centric," said Julio Triana, president of the Consumer Health division of Bayer. "Our aging journeys are unique to us all and new digital tools are enabling offerings to be more tailor made. With this multi-facedted approach, we are educating and enabling consumers to to make informed decisions about their self-care in new and exciting ways."

One A Day® Age Factor™ Cell Defense

As people age, their cells naturally become less effective at managing everyday stressors. Cellular or biological age - how a person's cells are aging - may not always match one’s chronological age. Research suggests that genetics contributes only about 20% to the cellular aging process, with lifestyle (diet, exercise, stress) playing a large role. One A Day® Age Factor™ Cell Defense has key ingredients to help support consumers' cellular health and resilience as part of their healthy aging journey.

"The healthy aging space can be a confusing one for consumers with countless products making big promises," said Abbie Lennox, Head of Regulatory, Medical, Safety, Quality and Compliance for Consumer Health at Bayer. "That's why we took a science-led approach that focuses on the holistic factors that impact cellular age by equipping consumers with a product containing a key ingredient that helps defend against oxidative stress along with personalized recommendations and insights to best chart their own course."

Designed to provide holistic support along their healthy aging journey, the Age Factor™ ecosystem includes a dietary supplement, a wellness companion app, and a Chronomics biological age test to measure and track personal progress over time.

  • The Age Factor™ wellness companion app provides valuable insights and lifestyle recommendations based on a person’s current habits while tracking progress over time.
  • The Chronomics biological age test is a simple and convenient way to measure biological age through a non-invasive saliva test. Once sent to the lab, the sample will be analyzed and results received within weeks.

Benefit claims for Age Factor Cell Defense supplement have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Precision Health

Technology advancements have enabled a wave of new digital products such as diagnostics, apps, and therapeutics to help consumers better manage their health. An analysis conducted for Bayer found over 80 percent of consumers globally already demand greater healthcare personalization and precision consumer health products will make up 10-20 percent of the total consumer health market in 2030 worth an estimated value of $20-40 billion.

Last year Bayer launched a new business unit focused on developing new precision consumer health products.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...